SpringLeaf Therapeutics Receives $15,000,000 Series A Round

  • Feed Type
  • Date
    5/12/2011
  • Company Name
    SpringLeaf Therapeutics
  • Mailing Address
    8 St. Mary’s Street Boston, MA 02215
  • Company Description
    SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
  • Website
    http://www.springleaftx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    We have achieved promising preclinical results to date and anticipate clinical testing to initiate in late 2012. With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    North Bridge Venture Partners

By posting a comment, you agree to our terms and conditions.